Research Analysts’ Updated EPS Estimates for August 19th (ACHC, ACHR, ACRS, ALMS, AMD, AU, BHVN, BIIB, BILL, BNTX)

Research Analysts’ updated eps estimates for Monday, August 19th:

Acadia Healthcare (NASDAQ:ACHC) had its neutral rating reissued by analysts at Cantor Fitzgerald. They currently have a $90.00 target price on the stock.

Archer Aviation (NYSE:ACHR) had its overweight rating reissued by analysts at Cantor Fitzgerald. They currently have a $10.00 target price on the stock.

Aclaris Therapeutics (NASDAQ:ACRS) had its neutral rating reissued by analysts at HC Wainwright.

Alumis (NASDAQ:ALMS) had its overweight rating reissued by analysts at Cantor Fitzgerald.

Advanced Micro Devices (NASDAQ:AMD) had its buy rating reaffirmed by analysts at TD Cowen. The firm currently has a $210.00 price target on the stock.

AngloGold Ashanti (NYSE:AU) had its sector underperform rating reiterated by analysts at Scotiabank. They currently have a $30.00 price target on the stock, up from their previous price target of $27.00.

Biohaven (NYSE:BHVN) had its overweight rating reissued by analysts at Cantor Fitzgerald.

Biogen (NASDAQ:BIIB) had its buy rating reiterated by analysts at Needham & Company LLC. The firm currently has a $285.00 target price on the stock.

BILL (NYSE:BILL) had its positive rating reissued by analysts at Susquehanna. The firm currently has a $100.00 price target on the stock.

BioNTech (NASDAQ:BNTX) had its buy rating reissued by analysts at HC Wainwright. They currently have a $113.00 price target on the stock.

The Cigna Group (NYSE:CI) had its overweight rating reaffirmed by analysts at Cantor Fitzgerald. The firm currently has a $400.00 target price on the stock.

Centene (NYSE:CNC) had its overweight rating reaffirmed by analysts at Cantor Fitzgerald. They currently have a $90.00 target price on the stock.

CrowdStrike (NASDAQ:CRWD) had its overweight rating reissued by analysts at Cantor Fitzgerald. The firm currently has a $400.00 target price on the stock.

CVS Health (NYSE:CVS) had its neutral rating reaffirmed by analysts at Cantor Fitzgerald. The firm currently has a $62.00 target price on the stock.

Estée Lauder Companies (NYSE:EL) had its market perform rating reissued by analysts at Telsey Advisory Group. They currently have a $115.00 price target on the stock.

Elevance Health (NYSE:ELV) had its overweight rating reaffirmed by analysts at Cantor Fitzgerald. The firm currently has a $600.00 target price on the stock.

Equillium (NASDAQ:EQ) had its buy rating reiterated by analysts at HC Wainwright. They currently have a $5.00 target price on the stock.

EVE (NYSE:EVEX) had its overweight rating reiterated by analysts at Cantor Fitzgerald. The firm currently has a $5.00 price target on the stock.

EVgo (NYSE:EVGO) had its overweight rating reiterated by analysts at Cantor Fitzgerald. Cantor Fitzgerald currently has a $5.00 price target on the stock.

Forte Biosciences (NASDAQ:FBRX) had its buy rating reiterated by analysts at Chardan Capital. Chardan Capital currently has a $3.00 price target on the stock.

fuboTV (NYSE:FUBO) had its buy rating reiterated by analysts at Needham & Company LLC. They currently have a $2.00 target price on the stock.

Grab (NASDAQ:GRAB) had its buy rating reissued by analysts at Benchmark Co.. They currently have a $6.00 target price on the stock.

GitLab (NASDAQ:GTLB) had its overweight rating reissued by analysts at Cantor Fitzgerald. They currently have a $55.00 target price on the stock.

HCA Healthcare (NYSE:HCA) had its overweight rating reissued by analysts at Cantor Fitzgerald. Cantor Fitzgerald currently has a $392.00 target price on the stock.

Humana (NYSE:HUM) had its neutral rating reiterated by analysts at Cantor Fitzgerald. They currently have a $395.00 target price on the stock.

Immix Biopharma (NASDAQ:IMMX) had its buy rating reissued by analysts at HC Wainwright. They currently have a $7.00 target price on the stock.

Innoviz Technologies (NASDAQ:INVZ) had its overweight rating reiterated by analysts at Cantor Fitzgerald. They currently have a $2.00 price target on the stock.

Janux Therapeutics (NASDAQ:JANX) had its buy rating reissued by analysts at HC Wainwright. HC Wainwright currently has a $63.00 target price on the stock.

JD.com (NASDAQ:JD) had its neutral rating reissued by analysts at Susquehanna. The firm currently has a $28.00 price target on the stock.

Joby Aviation (NYSE:JOBY) had its overweight rating reissued by analysts at Cantor Fitzgerald. The firm currently has a $10.00 target price on the stock.

KALA BIO (NASDAQ:KALA) had its outperform rating reaffirmed by analysts at Oppenheimer Holdings Inc.. The firm currently has a $15.00 target price on the stock.

Kronos Bio (NASDAQ:KRON) had its buy rating reiterated by analysts at HC Wainwright. HC Wainwright currently has a $2.25 target price on the stock.

Lucid Group (NASDAQ:LCID) had its neutral rating reissued by analysts at Cantor Fitzgerald. The firm currently has a $4.00 target price on the stock.

LeddarTech (NASDAQ:LDTC) had its hold rating reissued by analysts at Westpark Capital.

Lilium (NASDAQ:LILM) had its overweight rating reiterated by analysts at Cantor Fitzgerald. The firm currently has a $2.00 target price on the stock.

Eli Lilly and Company (NYSE:LLY) had its overweight rating reissued by analysts at Cantor Fitzgerald. They currently have a $885.00 price target on the stock.

Liquidia (NASDAQ:LQDA) had its buy rating reaffirmed by analysts at Needham & Company LLC. The firm currently has a $25.00 target price on the stock.

Lyell Immunopharma (NASDAQ:LYEL) had its neutral rating reissued by analysts at HC Wainwright. The firm currently has a $1.00 price target on the stock.

Molina Healthcare (NYSE:MOH) had its overweight rating reissued by analysts at Cantor Fitzgerald. They currently have a $406.00 target price on the stock.

NuCana (NASDAQ:NCNA) had its outperform rating reaffirmed by analysts at Oppenheimer Holdings Inc.. They currently have a $150.00 price target on the stock.

NVIDIA (NASDAQ:NVDA) had its buy rating reaffirmed by analysts at The Goldman Sachs Group, Inc.. The firm currently has a $135.00 price target on the stock.

Novo Nordisk A/S (NYSE:NVO) had its overweight rating reiterated by analysts at Cantor Fitzgerald. The firm currently has a $160.00 price target on the stock.

OmniAb (NASDAQ:OABI) had its buy rating reiterated by analysts at Benchmark Co.. They currently have a $8.00 target price on the stock.

Ovid Therapeutics (NASDAQ:OVID) had its buy rating reiterated by analysts at HC Wainwright. The firm currently has a $3.00 target price on the stock.

Palo Alto Networks (NASDAQ:PANW) had its overweight rating reiterated by analysts at Cantor Fitzgerald. The firm currently has a $350.00 price target on the stock.

Pfizer (NYSE:PFE) had its overweight rating reaffirmed by analysts at Cantor Fitzgerald. They currently have a $45.00 price target on the stock.

Phathom Pharmaceuticals (NASDAQ:PHAT) had its buy rating reaffirmed by analysts at Needham & Company LLC. Needham & Company LLC currently has a $26.00 price target on the stock.

Rubrik (NYSE:RBRK) had its overweight rating reissued by analysts at Cantor Fitzgerald. Cantor Fitzgerald currently has a $50.00 price target on the stock.

Roivant Sciences (NASDAQ:ROIV) had its buy rating reiterated by analysts at HC Wainwright. HC Wainwright currently has a $18.00 target price on the stock.

scPharmaceuticals (NASDAQ:SCPH) had its buy rating reissued by analysts at HC Wainwright. The firm currently has a $18.00 price target on the stock.

Sweetgreen (NYSE:SG) had its neutral rating reissued by analysts at Piper Sandler. They currently have a $39.00 price target on the stock, up from their previous price target of $33.00.

Surgery Partners (NASDAQ:SGRY) had its overweight rating reissued by analysts at Cantor Fitzgerald. They currently have a $43.00 price target on the stock.

Snowflake (NYSE:SNOW) had its buy rating reissued by analysts at Rosenblatt Securities. Rosenblatt Securities currently has a $195.00 target price on the stock.

Spruce Biosciences (NASDAQ:SPRB) had its neutral rating reiterated by analysts at HC Wainwright.

Tenet Healthcare (NYSE:THC) had its overweight rating reiterated by analysts at Cantor Fitzgerald. The firm currently has a $168.00 target price on the stock.

Trimble (NASDAQ:TRMB) had its overweight rating reiterated by analysts at Piper Sandler. Piper Sandler currently has a $73.00 target price on the stock.

Tesla (NASDAQ:TSLA) had its overweight rating reaffirmed by analysts at Piper Sandler. Piper Sandler currently has a $300.00 target price on the stock.

Universal Health Services (NYSE:UHS) had its neutral rating reiterated by analysts at Cantor Fitzgerald. They currently have a $219.00 price target on the stock.

UnitedHealth Group (NYSE:UNH) had its overweight rating reaffirmed by analysts at Cantor Fitzgerald. The firm currently has a $591.00 price target on the stock.

Williams-Sonoma (NYSE:WSM) had its outperform rating reaffirmed by analysts at Telsey Advisory Group. Telsey Advisory Group currently has a $170.00 target price on the stock.

ZIM Integrated Shipping Services (NYSE:ZIM) had its buy rating reissued by analysts at Jefferies Financial Group Inc.. Jefferies Financial Group Inc. currently has a $22.00 price target on the stock.

Zscaler (NASDAQ:ZS) had its neutral rating reiterated by analysts at Cantor Fitzgerald. Cantor Fitzgerald currently has a $200.00 price target on the stock.